It has higher immunogenicity, higher enrichment by tumor-infiltrating lymphocytes (TILs), higher tumor mutation load (TMB), and higher levels of programmed cell death ligand 1 (PD-L1) expression. This evidence concerns the gene CD274 and neoplasm.